Toshiyuki Sugiura

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Intravenous ω‐3 and ω‐6 Fat Emulsion on Cytokine Production and Delayed Type Hypersensitivity in Burned Rats Receiving Total Parenteral Nutrition

Naganori Hayashi, Tsuguhiko Tashiro, Hideo Yamamori et al. · Journal of Parenteral and Enteral Nutrition · 1998 · 77 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Effect of intravenous ω-6 and ω-3 fat emulsions on nitrogen retention and protein kinetics in burned rats

Naganori Hayashi, Tsuguhiko Tashiro, Hideo Yamamori et al. · Nutrition · 1999 · 42 citations

Life Sciences, Nutrition, Nutritional Sciences +15